|
1
|
Greenlee RT, Murray T, Bolden S and Wingo
PA: Cancer statistics, 2000. CA Cancer J Clin. 50:7–33. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Saavedra KP, Brebi PM and Roa JC:
Epigenetic alterations in preneoplastic and neoplastic lesions of
the cervix. Clin Epigenetics. 4:132012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zeller C, Hinzmann B, Seitz S, Prokoph H,
Burkhard-Goettges E, Fischer J, Jandrig B, Schwarz LE, Rosenthal A
and Scherneck S: SASH1: A candidate tumor suppressor gene on
chromosome 6q24.3 is downregulated in breast cancer. Oncogene.
22:2972–2983. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kim CA, Gingery M, Pilpa RM and Bowie JU:
The SAM domain of polyhomeotic forms a helical polymer. Nat Struct
Biol. 9:453–457. 2002.PubMed/NCBI
|
|
5
|
Pawson T: Protein modules and signalling
networks. Nature. 373:573–580. 1995. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Meng Q, Zheng M, Liu H, Song C, Zhang W,
Yan J, Qin L and Liu X: SASH1 regulates proliferation, apoptosis,
and invasion of osteosarcoma cell. Mol Cell Biochem. 373:201–210.
2013. View Article : Google Scholar
|
|
7
|
Rimkus C, Martini M, Friederichs J,
Rosenberg R, Doll D, Siewert JR, Holzmann B and Janssen KP:
Prognostic significance of downregulated expression of the
candidate tumour suppressor gene SASH1 in colon cancer. Brit J
Cancer. 95:1419–1423. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu GS, Song YL, Yin ZQ, Guo JJ, Wang SP,
Zhao WW, Chen XP, Zhang QW, Lu JJ and Wang YT: Ganoderiol
A-enriched extract suppresses migration and adhesion of MDA-MB-231
cells by inhibiting FAK-SRC-paxillin cascade pathway. PLoS One.
8:e766202013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chambers AF and Matrisian LM: Changing
views of the role of matrix metalloproteinases in metastasis. J
Natl Cancer Inst. 89:1260–1270. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
McCawley LJ and Matrisian LM: Matrix
metalloproteinases: Multifunctional contributors to tumor
progression. Mol Med Today. 6:149–156. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen EG, Chen Y, Dong LL and Zhang JS:
Effects of SASH1 on lung cancer cell proliferation, apoptosis, and
invasion in vitro. Tumor Biol. 33:1393–1401. 2012. View Article : Google Scholar
|
|
12
|
Beshir AB, Ren G, Magpusao AN, Barone LM,
Yeung KC and Fenteany G: Raf kinase inhibitor protein suppresses
nuclear factor-κB-dependent cancer cell invasion through negative
regulation of matrix metalloproteinase expression. Cancer Lett.
299:137–149. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Z, Li Y, Banerjee S, Kong D, Ahmad A,
Nogueira V, Hay N and Sarkar FH: Down-regulation of Notch-1 and
Jagged-1 inhibits prostate cancer cell growth, migration and
invasion and induces apoptosis via inactivation of Akt, mTOR, and
NF-kappaB signaling pathways. J Cell Biochem. 109:726–736.
2010.PubMed/NCBI
|
|
14
|
Arozarena I, Sanchez-Laorden B, Packer L,
Hidalgo-Carcedo C, Hayward R, Viros A, Sahai E and Marais R:
Oncogenic BRAF induces melanoma cell invasion by downregulating the
cGMP-specific phosphodiesterase PDE5A. Cancer Cell. 19:45–57. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lai WC, Zhou M, Shankavaram U, Peng G and
Wahl LM: Differential regulation of lipopolysaccharide-induced
monocyte matrix metalloproteinase (MMP)-1 and MMP-9 by p38 and
extracellular signal-regulated kinase 1/2 mitogen-activated protein
kinases. J Immunol. 170:6244–6249. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bauvois B: New facets of matrix
metalloproteinases MMP-2 and MMP-9 as cell surface transducers:
Outside-in signaling and relationship to tumor progression. Biochim
Biophys Acta. 1825:29–36. 2012.
|
|
17
|
Luo M and Guan JL: Focal adhesion kinase:
A prominent determinant in breast cancer initiation, progression
and metastasis. Cancer Lett. 289:127–139. 2010. View Article : Google Scholar :
|
|
18
|
Lark AL, Livasy CA, Calvo B, Caskey L,
Moore DT, Yang X and Cance WG: Overexpression of focal adhesion
kinase in primary colorectal carcinomas and colorectal liver
metastases: Immunohistochemistry and real-time PCR analyses. Clin
Cancer Res. 9:215–222. 2003.PubMed/NCBI
|
|
19
|
Zhao J and Guan JL: Signal transduction by
focal adhesion kinase in cancer. Cancer Metastasis Rev. 28:35–49.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ward KK, Tancioni I, Lawson C, Miller NL,
Jean C, Chen XL, Uryu S, Kim J, Tarin D, Stupack DG, et al:
Inhibition of focal adhesion kinase (FAK) activity prevents
anchorage-independent ovarian carcinoma cell growth and tumor
progression. Clin Exp Metastasis. 30:579–594. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yom CK, Noh DY, Kim WH and Kim HS:
Clinical significance of high focal adhesion kinase gene copy
number and overexpression in invasive breast cancer. Breast Cancer
Res Treat. 128:647–655. 2011. View Article : Google Scholar
|
|
22
|
John JK, Paraiso KH, Rebecca VW, Cantini
LP, Abel EV, Pagano N, Meggers E, Mathew R, Krepler C, Izumi V, et
al: GSK3β inhibition blocks melanoma cell/host interactions by
downregulating N-cadherin expression and decreasing FAK
phosphorylation. J Invest Dermatol. 132:2818–2827. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Aguirre Ghiso JA: Inhibition of FAK
signaling activated by urokinase receptor induces dormancy in human
carcinoma cells in vivo. Oncogene. 21:2513–2524. 2002. View Article : Google Scholar : PubMed/NCBI
|
